Disease burden and treatment preference for moderate‐to‐severe atopic dermatitis in Taiwan: A discrete‐choice experiment
The Journal of Dermatology · 2025
DOI: 10.1111/1346-8138.17721 ↗Kurz gefasst
Fachartikel in der Zeitschrift The Journal of Dermatology, 2025. Verfasst von Yung-Tsu Cho und 12 weiteren Autor:innen. Beteiligte Einrichtung: Department of Dermatology, National Taiwan University Hospital, Taipei, Taiwan. Hauptthemen laut MEDLINE: Dermatitis, Atopic, Patient Preference, Cost of Illness. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 30 Literaturangaben. Gefördert von: Atopic Dermatitis Patient Association (ADPA) (Taiwan).
Abstract (Originalsprache)
This study aimed to elicit the preferred treatment attributes of patients with atopic dermatitis (AD) and caregivers, and their willingness to pay based on preferred treatment attributes in Taiwan. A cross‐sectional, self‐administered, online survey study in Taiwan was conducted between March 2022 and July 2023 among adult AD patients (aged >20 years) ( n = 40) and caregivers of teenage AD patients (aged 12–19 years) ( n = 10). Survey items included disease burden, out‐of‐pocket costs, willingness to pay, and assessment of treatment attributes using discrete‐choice experiment. Hierarchical Bayesian logistic regression was used to quantify preferences and the relative importance of the attributes. Most responders (88%) rated ≤40 in a 100‐scale questionnaire regarding quality‐of‐lfe due to AD without effective treatment. “Probability of skin clearance” was the most important attribute while choosing advanced AD therapy, followed by “Probability of itch reduction”, “Risk of severe side effects”, “Route and frequency of administration”, and “Time‐to‐onset of itch relief”. The proportion of unwillingness to pay decreased from 14.7% to 2.9% with reducing time‐to‐onset of itch relief and increasing skin clearance probability. Patients with AD and caregivers valued treatment benefits the most and were willing to accept an increase in severe side effects for increased probability of skin clearance and itch reduction.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Dermatology, National Taiwan University Hospital, Taipei, Taiwan.
- Department of Dermatology, National Taiwan University College of Medicine, Taipei, Taiwan.
- Oracle Life Sciences, Taipei, Taiwan.
- Department of Dermatology, Kaohsiung Medical University Hospital, Kaohsiung Medical University, Kaohsiung, Taiwan.
- Department of Dermatology, College of Medicine, National Cheng Kung University Hospital, National Cheng Kung University, Tainan, Taiwan.
- Department of Dermatology, Chung Shan Medical University Hospital, Taichung City, Taiwan.
ORCID-Profile: Yin-Chun Chen, Chao-Kai Hsu, Han-Chi Tseng, Yu-Ching Weng, Po-Yuan Wu
Förderung
- Atopic Dermatitis Patient Association (ADPA) (Taiwan)
Zitieren
APA
Cho, Y. T., Chou, H. I., Chan, T. C., Chen, Y. C., Hsu, C. K., Lai, P. J., Tseng, H. C., Weng, Y. C., Wu, P. Y., Wu, W. H., Yu, Y., Huang, H., & Chu, C. Y. (2025). Disease burden and treatment preference for moderate‐to‐severe atopic dermatitis in Taiwan: A discrete‐choice experiment. The Journal of Dermatology. https://doi.org/10.1111/1346-8138.17721
Vancouver
Cho YT, Chou HI, Chan TC, Chen YC, Hsu CK, Lai PJ, et al. Disease burden and treatment preference for moderate‐to‐severe atopic dermatitis in Taiwan: A discrete‐choice experiment. The Journal of Dermatology. 2025. doi:10.1111/1346-8138.17721
BibTeX
@article{Cho2025,
author = {Cho, Yung-Tsu and Chou, Hsin-I and Chan, Tom C and Chen, Yin-Chun and Hsu, Chao-Kai and Lai, Po-Ju and Tseng, Han-Chi and Weng, Yu-Ching and Wu, Po-Yuan and Wu, Wei-Hsin and Yu, Yu and Huang, Hazel and Chu, Chia-Yu},
title = {Disease burden and treatment preference for moderate‐to‐severe atopic dermatitis in Taiwan: A discrete‐choice experiment},
journal = {The Journal of Dermatology},
year = {2025},
doi = {10.1111/1346-8138.17721}
}
EUVIMED